Allianz Asset Management Gmb H Summit Therapeutics Inc. Transaction History
Allianz Asset Management Gmb H
- $72.3 Billion
- Q4 2024
A detailed history of Allianz Asset Management Gmb H transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 44,800 shares of SMMT stock, worth $918,400. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,800
Previous 58,737
23.73%
Holding current value
$918,400
Previous $1.29 Million
37.87%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SMMT
# of Institutions
202Shares Held
76.3MCall Options Held
2.01MPut Options Held
2.83M-
Baker Bros. Advisors LP New York, NY24.4MShares$501 Million5.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$224 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$162 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.44MShares$112 Million0.01% of portfolio
-
State Street Corp Boston, MA3.47MShares$71.1 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.12B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...